Literature DB >> 20562645

Onset of catatonia at puberty: electroconvulsive therapy response in two autistic adolescents.

Neera Ghaziuddin1, Daniel Gih, Virginia Barbosa, Daniel F Maixner, Mohammad Ghaziuddin.   

Abstract

Catatonia is a syndrome of motor and behavioral disturbance. It is a poorly understood condition, which is underrecognized and may go untreated despite intensive medical workup and numerous unsuccessful medication trials. However, with treatments known to be effective, such as benzodiazepines and/or electroconvulsive therapy, patients may return to their baseline functioning. Autism and catatonia have been previously reported together. We report 2 patients with autism and mental retardation who developed catatonic symptoms at the onset of puberty. Both patients experienced persistent symptoms over several years and presented with a history of motor disturbance, functional decline, and episodic aggression. Both patients were treated with electroconvulsive therapy resulting in a positive response and functional improvement. Catatonia may persist as a chronic condition, lasting over several months or years, if not recognized and treated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562645     DOI: 10.1097/YCT.0b013e3181de332e

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  3 in total

Review 1.  Catatonia in patients with autism: prevalence and management.

Authors:  Luigi Mazzone; Valentina Postorino; Giovanni Valeri; Stefano Vicari
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

Review 2.  A systematic review of interventions used to treat catatonic symptoms in people with autistic spectrum disorders.

Authors:  Hannah DeJong; Penny Bunton; Dougal J Hare
Journal:  J Autism Dev Disord       Date:  2014-09

3.  Use of electroconvulsive therapy in an adolescent patient with catatonia.

Authors:  Sandeep Grover; Natasha Kate; Gaurav Gupta
Journal:  Indian J Psychol Med       Date:  2014-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.